BPC-157
10 mg vial, 60 capsules
So, what is TB 500 in one line? A lab-made chain of just seven amino acids, Ac-LKKTETQ, lifted from the actin-binding part of thymosin beta-4. That parent is a protein of 43 residues present in nearly every cell of the body. Keep one caveat in mind from the start. The studies most often cited for TB-500 were run with that full protein, not with the short fragment sold under the name.
Spelled out, the TB-500 peptide sold to researchers is usually Leu-Lys-Lys-Thr-Glu-Thr-Gln, an acetylated copy of positions 17 to 23 in Tβ4, written Ac-LKKTETQ. Those seven positions make up the core motif Tβ4 uses to hold actin. The thinking behind the fragment is economical. Keep the stretch believed to drive actin binding and cell movement, drop the rest, and you get a molecule that is far cheaper to synthesise. At roughly 889 Da it carries about one fifth of the mass of the parent protein.
Labelling in this market is loose. A vial marketed as a "TB -500 peptide" may in fact hold full-length thymosin beta-4. A certificate of analysis settles the question through mass. Expect about 889 Da for the fragment and about 4963 Da for the full protein. Every AminoLab lot has its identity checked by mass spectrometry at an independent lab, and you can look up any lot on our COA lookup page.
Allan Goldstein's group first pulled thymosin beta-4 (Tβ4) out of calf thymus, hence the name. It soon became clear the protein is not specific to the thymus at all. It sits in almost every nucleated cell, with particularly rich stores in platelets and white blood cells. The molecule is 43 amino acids long, acetylated at the N-terminus and weighs close to 4963 Da.
Its main role inside the cell is to sequester actin. Tβ4 grabs individual actin units, known as G-actin, and keeps them on standby, and that reserve governs how quickly filaments can be assembled when a cell wants to change shape or crawl. Wounds close, vessels sprout and tissues remodel only when cells travel to where they are needed, which explains why Tβ4 turns up in research on each of those processes.
| TB-500 | Thymosin beta-4 | |
|---|---|---|
| Residues | 7 amino acids (Ac-LKKTETQ) | 43 amino acids |
| Molecular weight, roughly | About 889 Da | About 4963 Da |
| Where it comes from | Synthetic fragment, residues 17 to 23 | Natural protein, synthesised or recombinant for study |
| Trials in people | None published | Phase 1 to 3 trials, including eye drops (RGN-259) |
| WADA listing | Prohibited, S2 | Prohibited, S2 |
Most write-ups skip one awkward fact. The two best-known papers used the whole thymosin beta-4 molecule. One is the 1999 rat wound closure work by Malinda's team in the Journal of Investigative Dermatology. The other is the 2004 Nature paper from Bock-Marquette's team on mouse heart cell survival. Evidence of the same quality that a seven-residue piece matches those results simply does not exist. We think the honest approach is to treat TB-500 as a separate compound that borrows its literature, and to build experiments that test the fragment itself instead of taking equivalence for granted.
When people list TB 500 benefits, what they are really listing are areas of Tβ4 research.
Not one of those findings comes from giving the Ac-LKKTETQ fragment to people. Ask what does TB 500 do in a human and the truthful answer is that no published trial exists to tell us.
With no published safety data on the fragment in people, any confident list of TB-500 side effects would be guesswork. The closest data concern the full protein. A 2010 paper in the Annals of the New York Academy of Sciences, from Ruff's group, describes healthy volunteers given synthetic Tβ4 intravenously, first as one-off amounts between 42 and 1260 mg and then once a day for 14 days. Reported adverse events were few, all mild or moderate, with no dose-limiting toxicity. Recombinant Tβ4 has also had a first-in-human phase 1 trial, run in healthy volunteers in China and reported in 2021 by the Journal of Cellular and Molecular Medicine.
On the theoretical side, the concern echoes the one raised for BPC-157. Anything that drives new vessels and moving cells can, in principle, help a tumour too, and oncology papers have tied strong Tβ4 expression to metastasis and invasion. Examples include a 2004 experiment in SW480 colon carcinoma cells and subsequent colorectal tumour series. Those papers concern Tβ4 the body makes itself, inside tumours, so they are not evidence that TB-500 causes cancer, yet it is exactly why long-term safety cannot be taken as read. Then there is product quality. The TGA singled out TB-500 in April 2026 in a warning about unapproved peptide products, pointing to mislabelling and contamination in vials sold online.
Sport is clear cut. TB-500, like every other derivative of thymosin beta-4, appears on the WADA Prohibited List in class S2 (peptide hormones, growth factors, related substances and mimetics), meaning it is banned at all times, in competition or not. BPC-157 has a separate S0 entry, explained in our BPC-157 side effects review.
Researchers often study TB-500 next to BPC-157, the gastric pentadecapeptide, since each is thought to work through a different route. For TB-500 that route is actin and cell migration, while BPC-157 is linked to nitric oxide and growth factor signalling. The side-by-side comparison of BPC-157 and TB-500 explains when two separate vials are the better choice and when the Wolverine Blend makes more sense. Working out concentration for a 10 mg vial takes seconds in the TB-500 reconstitution calculator.
There is only one format, a 10 mg lyophilised vial, so the decision is really about what you add alongside it. Order the plain fragment when the study question is what Ac-LKKTETQ does by itself, and let the certificate's mass reading, about 889 Da, prove the vial holds the fragment. If your design weighs the actin route against the growth factor route, add a separate BPC-157 vial, or pick the Wolverine Blend if the two compounds will only ever be run together. Hunting for TB-500 near me? Skip the local hunt. Our Australian warehouse posts it to any lab in the country. Add the TB-500 10 mg vial to your cart, along with bacteriostatic water.
You will find TB-500 in our tissue repair peptide category. It is supplied for bench research only, is not for humans or animals, and the TGA has never approved it as a therapeutic good.
It is Ac-LKKTETQ, a seven amino acid synthetic copy of the stretch of thymosin beta-4 that binds actin, positions 17 to 23. Researchers use it in work on wound healing, cell migration and blood vessel growth. It is not an approved medicine.
No. At 43 amino acids and roughly 4963 Da, thymosin beta-4 is the parent, and the TB-500 fragment is only seven residues, roughly 889 Da. Since most published work used the full protein, read the molecular weight on the certificate of analysis to see which one a vial holds.
Not for the fragment, because no human safety study of TB-500 has been published. The full protein went through a 2010 phase 1 trial in which adverse events were rare and no worse than moderate. What remains is partly theory, because the molecule drives angiogenesis and moving cells, and partly practical, since unverified products can be contaminated.
Cell culture and animal work on the whole thymosin beta-4 protein, which found quicker wound closure, more migration, angiogenesis and improved survival of heart cells. No controlled trial in people has demonstrated that the TB-500 fragment reproduces any of these effects.
Yes. The S2 class of the WADA list, which takes in peptide hormones, growth factors, related substances and mimetics, names thymosin beta-4 and its derivatives, so TB-500 is prohibited at all times. What the label calls the product makes no difference.
Order it online from AminoLab for laboratory research. Before starting, confirm the certificate shows roughly 889 Da, the mass of the fragment. It is not TGA approved, and people and animals must not receive it.
10 mg vial, 60 capsules
50 mg vial, 100 mg vial
10 mg vial
3 mL, 3 mL + 1 syringe, 10 mL, 10 mL + 1 syringe, 30 mL, 30 mL + 1 syringe
Research use onlyAminoLab supplies research compounds for laboratory and in-vitro use, not for human or animal consumption. By continuing you confirm you are 18 or older and buying for research.
Leave